Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
Bristol-Myers Squibb: Business Development in a Global Community




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Bristol-Myers Squibb: Business Development in a Global Community
Released on: November 01, 2007. © PharmaVentures Ltd
Visitors: You are watching a 5 minute preview.
Get more information and subscribe now
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this exclusive interview, Fintan Walton talks to Graham Brazier, Vice President and Head of Business Development at Bristol-Myers Squibb (BMS), about the world of big pharma business development and the process of in-licensing.
  • Summary
  • Transcript
  • Participants
  • Company
In this exclusive interview, Fintan Walton talks to Graham Brazier, Vice President and Head of Business Development at Bristol-Myers Squibb (BMS), about the world of big pharma business development and the process of in-licensing. Because the interview took place at the AusBiotech 2007 conference, particular reference is made to the importance and challenges of making deals in Australia. Graham also details the rationale between BMS’ collaborations with fellow big pharma companies AstraZeneca and Pfizer, as well as discussing BMS’ acquisition of Adnexus.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Before joining Bristol-Myers Squibb as Vice President and Head of Business Development in April 2002, Graham Brazier was Senior Vice President, Corporate Development, 3-Dimensional Pharmaceuticals, where he was responsible for business and corporate development as well as developing and maintaining relationships with investment banks and the investment community. Before this, he was Vice President, Worldwide Business Development, Pharmaceuticals, at SmithKline Beecham (now GlaxoSmithKline), responsible for co-promotion agreements, in- and out-licensing, research collaborations, patent licences, biotech acquisitions and various other strategic alliances.
Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb manufactures prescription pharmaceuticals in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders. It is also the parent company of Mead Johnson Nutrition, which manufactures nutritional products such as Enfamil baby formulas and infant vitamin supplements like Tri-Vi-Sol. Bristol-Myers Squibb has a mission to "Extend and Enhance Human Life" and works to discover and develop medicines in areas of serious unmet medical need.